Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

CONTEXT: For patients with metastatic papillary thyroid carcinoma (PTC) refractory to radioactive iodine (RAI) treatment, systemic chemotherapy has limited efficacy. Such tumors frequently harbor BRAF V600E, and this alteration may predict responsiveness to vemurafenib treatment. OBJECTIVE: We repor...

Full description

Saved in:
Bibliographic Details
Main Authors: Ali, Siraj M., He, Je, Carson, Wade, Stephens, Phil J., Fiorillo, Joseph, Lipson, Doron, Palmer, Gary A., Ross, Jeffrey S., Miller, Vincent A., Sharman, Jeffrey
Format: Artigo
Language:Inglês
Published: S. Karger AG 2014
Subjects:
Published online: May, 2014
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4067722/
https://ncbi.nlm.nih.gov/pubmed/24987354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000363377
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items